
|Slideshows|June 22, 2017
Update on Migraine and Parkinson Disease: 3 New Studies
Author(s)Mark L. Fuerst
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Apitegromab for Spinal Muscular Atrophy
2
8 Emerging Therapies Shaping the Muscular Dystrophy Treatment Landscape
3
Exploring the Unmet Needs in CIDP
4
Zilganersen FAQs: What Clinicians Should Know About the First Approved Treatment for Alexander Disease
5

















